cGxP.wire https://validator.w3.org/feed/docs/rss2.html Ambrosia’s AMB-702 Shows Superior Weight Loss in Preclinical GLP-1 Studies Lilly’s Foundayo Shows Strong Weight Loss Across Menopause Novo Nordisk’s CagriSema Delivers Superior Diabetes Control Clarius Wins FDA Clearance for AI Cardiac Ultrasound Tool Lupin Wins FDA Approval for Ranluspec Biosimilar Eye Drug Altesa’s Vapendavir Shows Promise in Preventing COPD Flares VetrixBio’s VTX-304 Shows Promise for Canine Osteoarthritis Neuronoff Implants First Patient in Injectrode Bladder Trial Vivos Submits FDA IDE for RadioGel Therapy NRx Pharmaceuticals Highlights Real-World Ketamine Depression Data Edesa Biotech Reports Positive Paridiprubart AKI Data Zealand Pharma Reports Positive Phase 2 Petrelintide Data in Obesity Tandem Diabetes Care Expands CE Mark for AID Systems Memo Therapeutics Phase II Potravitug Shows Strong BKPyV Clearance Teva Reports Real-World Benefits of AUSTEDO for Huntington’s Disease Chorea Rivus Highlights RV-8451 Muscle-Preserving Obesity Data Shattuck Labs to Present Phase 1 Data for SL-325 on June 8 Structure Therapeutics Highlights Aleniglipron Phase 2b Success Retia and Medtronic Expand Access to Argos Cardiac Monitoring Technology in Western Europe Zealand Pharma Highlights Positive Phase III Survodutide Results in Obesity Ascletis Showcases Next-Generation Obesity Pipeline at ADA 2026 Berobenatide Shows Strong Weight Loss With Monthly Dosing OriCell’s Ori-C101 Advances to Phase II Trial in Liver Cancer Eos SENOLYTIX Highlights PTC-2105 Preclinical Data at Obesity Forum Mabwell Receives NMPA Clearance for 9MW5211 in Inflammatory Bowel Disease Climb Bio Advances CLYM116 After Encouraging Phase 1 Safety Results Amneal Reports Positive Phase 4 ELEVATE-PD Results for CREXONT Jazz Highlights New Xywav Data Across Narcolepsy and Idiopathic Hypersomnia BioCardia Gains FDA Support for Heart Failure Therapy Novo Nordisk Reports Strong Phase 2 Zenagamtide Data Zepto Receives FDA Breakthrough Designation for FungiFlex Test Biogen Highlights Kidney Disease Data at ERA and ATC 2026 Rise Therapeutics Completes Enrollment in R-2487 Rheumatoid Arthritis Trial Novo Nordisk Launches Wegovy Pill in UAE Market Teva Reports New AUSTEDO Data in Huntington’s Chorea Elanco Expands Response to New World Screwworm Threat Cycle Pharmaceuticals and Flex Pharma Advance CML Treatment with CAVHANZA Approval Kashiv BioSciences Moves Closer to Launching XOLAIR Biosimilar in Canada Regeneron Highlights Phase 3 FOP and Metabolic Data Alkem Launches India’s First Semaglutide Pre-Filled Syringe Otsuka’s VOYXACT Preserves Kidney Function in Phase 3 IgAN Trial Tenaya Reports Positive TN-201 Gene Therapy Data in MYBPC3-Associated HCM Lundbeck Reports Positive Phase IIb Migraine Trial Data NanoDetection and Oligomerix Partner to Advance Tau-Based Neurodegenerative Diagnostics Novo Nordisk’s CagriSema Delivers Strong HbA1c and Weight Loss Results in Phase 3 REIMAGINE Trials Chiesi Wins EU Approval for Pediatric LOJUXTA Use Vaxcyte Doses First Participant in Phase 1 Trial of VAX-A1 for Group A Strep Prevention Pfizer Partners with Chai Discovery to Accelerate AI-Powered Drug Discovery Tenaya Therapeutics Prepares New TN-201 Gene Therapy Data for Genetic Heart Disease Antag Therapeutics Reports Positive Phase 1 Results for AT7687 in Obesity